Preview Mode Links will not work in preview mode

May 6, 2021

Featuring perspectives from Drs Alexander Perl and Eunice S Wang, including the following topics:

  • Introduction (0:00)
  • Venetoclax combinations in the treatment of acute myeloid leukemia (AML) (5:15)
  • Role of FLT3 inhibitors in the treatment of AML (28:08)
  • Use of IDH inhibitors to treat AML (48:32)
  • Oral azacitidine (CC-486) in the treatment of AML (54:26)
  • Treatment with CPX-351 for patients with secondary AML (56:18)
  • Novel agents and strategies in the treatment of AML (58:08)

CME and select publications